World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01790321
Date of registration: 07/02/2013
Prospective Registration: No
Primary sponsor: Prof. Michael B. Zimmermann
Public title: Water-based Zinc Efficacy Trial in Beninese Shool Children
Scientific title: Efficacy Study of Water as Fortification Vehicle for Zinc for Improving Zinc Status in Primary Schools Children in the Municipality of Natitingou, North of Benin.
Date of first enrolment: February 2013
Target sample size: 278
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01790321
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)  
Phase:  N/A
Countries of recruitment
Benin
Contacts
Name:     Michael B Zimmermann, Prof. Dr.med
Address: 
Telephone:
Email:
Affiliation:  University of Zurich
Key inclusion & exclusion criteria

Inclusion Criteria:

- School aged children enrolled in primary school and regularly attending class

Exclusion Criteria:

- Severe anemia (Hb < 7 g/dl)

- Consumption of a supplement or dietary supplement containing zinc

- Use of drugs that affect the metabolism of zinc

- Suffering from a chronic disease affecting the metabolism of zinc



Age minimum: 6 Years
Age maximum: 10 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Zinc Deficiency
Intervention(s)
Device: LSF-filtering device
Primary Outcome(s)
Zinc status [Time Frame: Baseline, midpont (varying between weeks 5-20), endpoint (week 22)]
Secondary Outcome(s)
Anthropometric indices [Time Frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)]
Iron status [Time Frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)]
Diarrhea incidence [Time Frame: Weekly, from baseline through to endpoint]
Malaria prevalence [Time Frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)]
ALRI prevalence [Time Frame: At baseline and endpoint]
Inflammation status [Time Frame: Baseline, midpoint (varying between weeks 5-20), endpoint (week 22)]
Secondary ID(s)
LSF_Zn_school
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Université d'Abomey-Calavi
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history